SARS-CoV-2 infections in patients, health care workers and hospital outbreaks during the first 3 waves of the pandemic: a retrospective analysis in a secondary care hospital network in Germany.
Anke HildebrandtKirsten DolegaLutz UflackerHenrik RudolfSören G GatermannPublished in: BMC infectious diseases (2024)
This research was conducted in accordance with the Declaration of Helsinki and national standards. The study protocol was approved by the relevant ethics committee of the Chamber of Physicians Westphalia-Lippe and University of Münster (no. 2021-475-f-S). The study was registered on 25th August 2021 at the German Clinical Trials Register (DRKS00025865).
Keyphrases
- sars cov
- clinical trial
- healthcare
- end stage renal disease
- study protocol
- quality improvement
- ejection fraction
- randomized controlled trial
- chronic kidney disease
- newly diagnosed
- primary care
- peritoneal dialysis
- coronavirus disease
- public health
- palliative care
- prognostic factors
- acute care
- open label
- machine learning
- pain management
- patient reported outcomes
- phase ii
- patient reported
- network analysis
- artificial intelligence